Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share - Schedule of Potential Common Shares Outstanding Excluded from the Computation of Diluted Net Loss Per Share (Details)

v3.8.0.1
Net Loss Per Common Share - Schedule of Potential Common Shares Outstanding Excluded from the Computation of Diluted Net Loss Per Share (Details) - shares
shares in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Anti-dilutive securities    
Total common stock equivalents (in shares) 29,541 36,123
Options to purchase common stock    
Anti-dilutive securities    
Total common stock equivalents (in shares) 6,206 9,665
Restricted stock units    
Anti-dilutive securities    
Total common stock equivalents (in shares) 20,990 23,554
Performance awards    
Anti-dilutive securities    
Total common stock equivalents (in shares) 1,486 2,315
Employee stock    
Anti-dilutive securities    
Total common stock equivalents (in shares) 859 589